Business Proposal


Rupcco Pharma is registered under the laws of Kenya to carry on the business of Pharmaceutical distribution/wholesale retail and manufacturing among other functions. The pharmaceutical sector remains one of the most profitable areas of doing businesses in the East African region and beyond. In Kenya, the business has been boosted further by the provisions of the new constitution where the health functions have been devolved to the county government. Rupcco has a rare opportunity to trade with the forty seven (47) devolved government units. Kenya being the economic power house in East Africa region, coupled with its strategic location in the African continent makes it the destination of choice for pharmaceutical investors and Multinational Corporation eying Africa especially in the field of manufacturing and distribution. Kenya is currently the largest producer of pharmaceutical products in the common market for eastern and southern Africa (COMESA) region, supplying about 50% of the region’s market. Kenya’s pharmaceutical industry is on a rebound, riding on the back of increased expenditure in healthcare and general economic growth over the years. It is for the above reasons that Rupcco Pharma Ltd has come up with an idea of plying a leading role in this fast growing industry. The business idea presents a noble business opportunity to savvy investors, both local and foreign, who wish to invest in the Kenya’s pharmaceutical industry and Africa at large. Rupcco Pharma will need to raise a substantial startup capital to a tune of a minimum ksh 100million to be able to successfully venture in this lucrative sector.  Rupcco Pharma extends invitation to strategic partners to invest in this business venture.The company confidently promises its potential investors an annual return on investment ranging between 25 to 35 percent and earnigs per share in devideds ranging between 10% to 15% annually.
The ongoing integration of East African States allowing for free movement labor, goods and other factors of production will generate new and unexploited market opportunities which the early adopters will benefit immensely. Countries like Tanzania, Uganda and Rwanda rely heavily on Kenya for supplies of pharmaceutical products. The three East African Countries import from Kenyan market an average of over 70% of pharmaceutical products consumed in those countries. Consequently, Rupcco Pharma intends to have its low cost generic products registered in all the East African countries to benefit from this expanded market.
Rupcco Pharma expansion strategy is congizant of the challenges posed by social and political differences within the entire East African region and intends to take advantage of that reality.

The regional distribution points (Franchise outlets) will enjoy some levels of autonomy and territorial integrity.
Rupcco Pharma is intending to employ effective and advanced technology in its operations, communication and research as a sure source of competitive advantage over its closest competitors.
This distribution strategy adopted by Rupcco Pharma, coupled with targeted large capital base, experienced and highly skilled human capital,advanced technology, and overall involvement of locals in community pharmacy  is key to the sustaine growth of the company

Rupcco Pharma is partnering with foreign and local manufacturers enabling it to become the sole agent and distributors for their fast moving products.
To benefit from the above business opportunities, Rupcco Pharma will require huge capital, high level of expertise/professionalism, an unmatched level of connectivity/involvement with the manufacturing industries and relevant experience in the pharmaceutical industry/ market. This definitely cannot be achieved by an average individual investor. Rupcco has assembled a team of experts at strategy level to continuously map out overall corporate direction and operational strategies aimed at attainment of the vision in real time.


David Namu is a proven entrepreneur with wide range of experince in Pharmaceutical industry spanning over 15yrs. He is a Trained Pharmaceutical Technologist from Kenya Medical Training College and Fully Registered with Pharmacy and Poisons Board. He holds a degree in Strategic Management from school of business and Economics at Mount Kenya University. He is currently pursuing masters in Health management at Kenyatta University. He is an able team leader in Strategy Formulation, Implementation and evaluation. He is a founder member of Kenya Pharmaceutical Association and a competent entrepreneur with a wide range of  experience in the pharmaceutical industry spanning a period of over 15yrs. He worked at ET Monks pharmaceutical company and Kenyatta National Hospital before venturing in to private practice in the year 2000. He is a director in Concord Future Technologies and a valued founder member and president of Rupcco Pharma Ltd.



He is the chief executive officer (CEO) and head of management board
Strathmore Graduate- – Timothy holds a Bachelor of Commerce degree- Double major commerce and Strategy- from Strathmore University and IMIS certification. He brings in a wealth of experience in business administration and operations having previously worked at Safaricom and NIC bank. He also has Micro Finance and entrepreneurial skills important for strategy formulation. Timothy also has certification in Anti Money Laundering



He is the Company’s Pharmacist. He heads product development and Regulatory Affairs Department.
He holds a bachelor of Pharmacy from the University of Nairobi. He has previously as the manager  and company pharmacist with Robins Healthcare Ltd , Hospital Pharmacist in both Chukka and Meru Hospitals, as well as a company pharmacist with  Medivet products  manufacturing company .



He is the Chief Pharmacist in charge of logistics and Distribution chain network
He is a former Kenya pharmaceutical Association Nairobi Branch secretary general. He holds a degree in pharmacy from Mount Kenya University and a Diploma in Pharmacy from Kenya Medical Training College. He brings a wealth of experience having worked in Kenyatta National Hospital, University of Nairobi medical center, Kenya Medical Research Institute (KEMRI) and various pharmacy retail outlets in Kenya



Peter Silali Musundi
Business Development and Strategy
He holds a Bachelor in Strategic Management from Mount Kenya University school of Business and Economics. He also holds a Diploma in Business Management from the same institution. He is a lead team member in strategy formulation, implementation and evaluation at Rupcco Pharma.  He worked with Del Monte Kenya Ltd, Finance, before joining Rupcco Pharma.





He is a Kenyan businessman who has invested in several industries. He holds a Bachelor of Business degree with a double major in Management & Marketing from Edith Cowan University (ECU) in Perth, Western Australia. He is a former founding member of the gospel music group “Mission Driven” in which he served as chairman from 2000 to 2004, earning a nomination for Best Gospel Group during the 2003 KORA Awards in South Africa.

Increase Customer Satisfaction – Offer affordable and high quality generics and superior pricing strategy.
This strategy is underpinned by our continued focus on patient/customer needs and service, our work with governments to further their healthcare agendas, selective partnerships, and our strong financial disciplines.
Armed with a well thought out strategic plan developed over the last eight months, Rupcco Pharma has a planned share capitalization of 100, 000 shares valued at Ksh. 1000 each.


Rupcco Pharma aims to be among the leading pharmaceutical companies in the distribution of pharmaceutical products within the East Africa region in the next five years. The synergy that comes with every new partner will add value in the much needed capital and business networking especially by the practicing medics. The larger members of the public have a rear opportunity to invest in one of the most lucrative business sectors of the economy.

Recently, the company has taken a major milestone in its effort to grow and expand its business in the Kenyan market. This has seen it enter into distribution arrangement with some foreign pharmaceutical companies.
In line with the above information, Rupcco Pharma ltd seeks to invite likeminded local investors to buy shares in this company so that they can also benefit from this noble business venture with promising rewards. The minimum share contribution is 100 shares for practising medics and 1000 shares for other investors. The revenues generated from shares contribution shall boost the wholesale and distribution activities whereby medical shareholders/owners who are in private practice will qualify for goods on reasonable credit terms and at distributor prices.



leading system of networked pharmaceutical drugstores/franchises within the East African region by the year 2020”
“Rupcco Pharma brings a Franchise mix entrepreneurial opportunity to the local communities and  avail quality and affordable generic medicines with superior customer service, complemented by a strong sense of social purpose, and highly motivated team of professionals to bring customer satisfaction above all”.


Social Purpose
We believe that it is our responsibility to help the community and our countrymen. We recognize that the nature of our business, especially the corporate focus on quality affordable generic medicines, gives us a unique opportunity to make a very positive contribution to the health of the communities that we serve.

Management Plan
The CEO is the chairman of the management board which consists of all line managers.

Rupcco Pharma Structure
The company has adopted a two tier organizational stratucture. The board of directors and the management board

Corporate Expertise and Business Development

It shall be the obligation of the management team to deliver valaue and safeguard rights and benefits to the company’s shareholder/ owners.
Synergy emanating from ever expanding franchise network and strength of being associated with strong brands
The company intends to assist and empower potential investors with unmatched managerial skills in identifying a good location for their business, cash flow projections, planned growth and budgetary estimates, training, marketing, impacting Technical skills, manpower, tax returns, business licensing, business registration and establishment among others.


For application Guide